SG11202109876WA - Concealment of hypomineralised lesions - Google Patents
Concealment of hypomineralised lesionsInfo
- Publication number
- SG11202109876WA SG11202109876WA SG11202109876WA SG11202109876WA SG 11202109876W A SG11202109876W A SG 11202109876WA SG 11202109876W A SG11202109876W A SG 11202109876WA SG 11202109876W A SG11202109876W A SG 11202109876WA
- Authority
- SG
- Singapore
- Prior art keywords
- hypomineralised
- concealment
- lesions
- hypomineralised lesions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C19/00—Dental auxiliary appliances
- A61C19/06—Implements for therapeutic treatment
- A61C19/063—Medicament applicators for teeth or gums, e.g. treatment with fluorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/71—Fillers
- A61K6/74—Fillers comprising phosphorus-containing compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/15—Compositions characterised by their physical properties
- A61K6/16—Refractive index
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/838—Phosphorus compounds, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/03—Liquid compositions with two or more distinct layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2019900833A AU2019900833A0 (en) | 2019-03-13 | Concealment of hypomineralised lesions | |
AU2019903860A AU2019903860A0 (en) | 2019-10-14 | Concealment of hypomineralised lesions (2) | |
PCT/AU2020/050239 WO2020181335A1 (en) | 2019-03-13 | 2020-03-13 | Concealment of hypomineralised lesions |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202109876WA true SG11202109876WA (en) | 2021-10-28 |
Family
ID=72425942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202109876W SG11202109876WA (en) | 2019-03-13 | 2020-03-13 | Concealment of hypomineralised lesions |
Country Status (11)
Country | Link |
---|---|
US (1) | US20220183810A1 (en) |
EP (1) | EP3937881A4 (en) |
JP (1) | JP2022524856A (en) |
KR (1) | KR20210139320A (en) |
CN (1) | CN113811278A (en) |
AU (1) | AU2020234723A1 (en) |
BR (1) | BR112021018034A2 (en) |
CA (1) | CA3133098A1 (en) |
MX (1) | MX2021011094A (en) |
SG (1) | SG11202109876WA (en) |
WO (1) | WO2020181335A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2918441C (en) | 2013-07-23 | 2023-03-21 | The University Of Melbourne | A base and phosphopeptide stabilized amorphous calcium phosphate (acp) and/or amorphous calcium fluoride phosphate (acfp) for use in promoting remineralisation |
US10912722B2 (en) | 2013-12-24 | 2021-02-09 | The University Of Melbourne | Stabilized stannous compositions |
KR20190126141A (en) | 2017-03-14 | 2019-11-08 | 더 유니버시티 오브 멜버른 | Treatment for gingivitis |
AU2021350837A1 (en) * | 2020-09-28 | 2023-03-16 | The Procter & Gamble Company | Array of anticavity oral care compositions |
GB202110114D0 (en) * | 2021-07-14 | 2021-08-25 | Dentherapy Ltd | Oral care compositions for use in treaatment |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO566297A0 (en) * | 1997-03-13 | 1997-04-10 | University Of Melbourne, The | Calcium phosphopeptide complexes |
MXPA04006541A (en) * | 2002-01-03 | 2004-10-04 | Procter & Gamble | Stable oral compositions comprising casein phosphopeptide complexes and fluoride. |
US20050089481A1 (en) * | 2003-10-23 | 2005-04-28 | Gc Corporation | Composition for caries prevention |
CN101217932A (en) * | 2005-06-07 | 2008-07-09 | 墨尔本大学 | Dental mineralization |
PL2705826T3 (en) * | 2006-02-09 | 2020-11-02 | The University Of Melbourne | Fluoride composition and methods for dental mineralization |
CA2918441C (en) * | 2013-07-23 | 2023-03-21 | The University Of Melbourne | A base and phosphopeptide stabilized amorphous calcium phosphate (acp) and/or amorphous calcium fluoride phosphate (acfp) for use in promoting remineralisation |
BR112017013503A2 (en) * | 2014-12-24 | 2018-03-06 | The University Of Melbourne | mineralization fluoride compositions |
-
2020
- 2020-03-13 CN CN202080034171.XA patent/CN113811278A/en active Pending
- 2020-03-13 JP JP2021555285A patent/JP2022524856A/en active Pending
- 2020-03-13 WO PCT/AU2020/050239 patent/WO2020181335A1/en unknown
- 2020-03-13 CA CA3133098A patent/CA3133098A1/en active Pending
- 2020-03-13 BR BR112021018034A patent/BR112021018034A2/en unknown
- 2020-03-13 MX MX2021011094A patent/MX2021011094A/en unknown
- 2020-03-13 KR KR1020217032306A patent/KR20210139320A/en unknown
- 2020-03-13 US US17/438,299 patent/US20220183810A1/en active Pending
- 2020-03-13 AU AU2020234723A patent/AU2020234723A1/en active Pending
- 2020-03-13 EP EP20770138.4A patent/EP3937881A4/en active Pending
- 2020-03-13 SG SG11202109876W patent/SG11202109876WA/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2020181335A1 (en) | 2020-09-17 |
EP3937881A1 (en) | 2022-01-19 |
EP3937881A4 (en) | 2023-04-12 |
CN113811278A (en) | 2021-12-17 |
CA3133098A1 (en) | 2020-09-17 |
JP2022524856A (en) | 2022-05-10 |
MX2021011094A (en) | 2021-12-10 |
KR20210139320A (en) | 2021-11-22 |
AU2020234723A1 (en) | 2021-10-07 |
BR112021018034A2 (en) | 2021-11-23 |
US20220183810A1 (en) | 2022-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202109876WA (en) | Concealment of hypomineralised lesions | |
GB201905265D0 (en) | Inflammasome inhibition | |
CA195576S (en) | Inhaler | |
EP3801503A4 (en) | Inhibitors of sarm1 | |
IL291273A (en) | Intranasal administration of esketamine | |
EP3801500A4 (en) | Inhibitors of sarm1 | |
EP3801499A4 (en) | Inhibitors of sarm1 | |
IL283885A (en) | Cxcr7 inhibitors for the treatment of cancer | |
EP4058041C0 (en) | Compositions for the treatment of epithelial lesions | |
GB202009824D0 (en) | Inhaler | |
PL3808245T3 (en) | Endoscope | |
EP3772317C0 (en) | Endoscope | |
EP3814324A4 (en) | Cathepsin c inhibitors | |
EP3801525A4 (en) | Inhibitors of prolyl-trna-synthetase | |
ZA202105399B (en) | Use of spiropidion | |
IL290756A (en) | Treatment of azoles | |
IL288515A (en) | Cryo-ablation catheter | |
IL276107A (en) | Solid forms of fasoracetam | |
GB2587234B (en) | Endoscope | |
SG11202105136WA (en) | Application of chidamide | |
AU2019900833A0 (en) | Concealment of hypomineralised lesions | |
AU2019900626A0 (en) | Concealment of hypomineralised lesions | |
GB202205754D0 (en) | Detection of larp1 | |
AU2019903860A0 (en) | Concealment of hypomineralised lesions (2) | |
IL272124A (en) | Treatment of non-inflammatory lesions |